|
| Exchange Received Time 09/10/2018 18:47:40 Exchange Disseminated Time 09/10/2018 18:47:46 Time Taken 00:00:06 | Subject: Transfer of Company''s Active Pharmaceuticals Ingredient (API) Business.
Further to the earlier intimation dated September 25, 2018, announcing the shareholder approval for the above transaction, we hereby advise that a Business Purchase Agreement for transfer of the Company's API business to Glenmark Life Sciences Limited, a wholly owned subsidiary of the Company, has been executed on October 9, 2018.
The transaction is expected to be completed in the next 2-3 months. |
|
|